Evidence map›Paper›PMID 31596875›Full record

SynthesisPloS one2019

Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases.

Matthew Traylor, Rachel Knevel, Jing Cui, John Taylor, Westra Harm-Jan, Philip G Conaghan, Andrew P Cope, Charles Curtis, Paul Emery, Stephen Newhouse and 10 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Association ofGenetics research · 2021
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Matthew TraylorDepartment of Clinical Neurosciences, Stroke Research Group, University of Cambridge, Cambridge, United Kingdom.
Rachel KnevelBrigham and Women's Hospital, Division of Genetics, Raychaudhuri Lab, Boston, MA, United States of America.
Jing CuiDivision of Rheumatology Immunology and Allergy Brigham & Women's Hospital Harvard Medical School Boston, MA, United States of America.
John TaylorLeeds Institute of Cancer & Pathology, Worsley Building Level 11 (LIDA), Clarendon Way, Leeds, United Kingdom.
Westra Harm-JanBrigham and Women's Hospital, Division of Genetics, Raychaudhuri Lab, Boston, MA, United States of America.
Philip G ConaghanLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
Andrew P CopeAcademic Department of Rheumatology, Centre for Molecular and Cellular Biology of Inflammation, King's College London, London, United Kingdom.
Charles CurtisNIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.
Paul EmeryLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
Stephen NewhouseNIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.
Hamel PatelNIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.ORCID 0000-0001-7951-6728
Sophia SteerDepartment of Rheumatology, King's College Hospital, Denmark Hill, London, United Kingdom.
Peter GregersenThe Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York, United States of America.
Nancy A ShadickDivision of Rheumatology Immunology and Allergy Brigham & Women's Hospital Harvard Medical School Boston, MA, United States of America.
Michael E WeinblattDivision of Rheumatology Immunology and Allergy Brigham & Women's Hospital Harvard Medical School Boston, MA, United States of America.
Annette Van Der Helm-van MilDepartment of Rheumatology C1-R, Leiden University Medical Center, Albinusdreef, Leiden, the Netherlands.
Jennifer H BarrettNIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.ORCID 0000-0002-1720-7724
Ann W MorganLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
Cathryn M LewisDepartment of Medical and Molecular Genetics, King's College London, London, United Kingdom.
Ian C ScottPrimary Care Centre Versus Arthritis, Research Institute for Primary Care and Health Sciences, Primary Care Sciences, Keele University, Keele, United Kingdom.ORCID 0000-0002-1268-9808

Funding

Pharmacogenetics of Phase II Drug Metabolizing EnzymesU19GM061388 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2010 to 2014
$15.8M
British Heart FoundationCancer Research UKChief Scientist OfficeDepartment of Health 05/40/04Department of Health RP-PG-0407-10314Medical Research Council G0902393Medical Research Council G1001516Medical Research Council MC_PC_13041Medical Research Council MR/K006584/1Medical Research Council MR/K015346/1Medical Research Council MR/M501633/2NIGMS NIH HHS U19 GM061388Versus Arthritis 18387Versus Arthritis 18475Versus Arthritis 19739Versus Arthritis 20011Versus Arthritis 36661Wellcome Trust
6 · The paper itself

Abstract

backgroundPrevious studies of radiological damage in rheumatoid arthritis (RA) have used candidate-gene approaches, or evaluated single genome-wide association studies (GWAS). We undertook the first meta-analysis of GWAS of RA radiological damage to: (1) identify novel genetic loci for this trait; and (2) test previously validated variants.

methodsSeven GWAS (2,775 RA cases, of a range of ancestries) were combined in a meta-analysis. Radiological damage was assessed using modified Larsen scores, Sharp van Der Heijde scores, and erosive status. Single nucleotide polymophsim (SNP) associations with radiological damage were tested at a single time-point using regression models. Primary analyses included age and disease duration as covariates. Secondary analyses also included rheumatoid factor (RF). Meta-analyses were undertaken in trans-ethnic and European-only cases.

resultsIn the trans-ethnic primary meta-analysis, one SNP (rs112112734) in close proximity to HLA-DRB1, and strong linkage disequilibrium with the shared-epitope, attained genome-wide significance (P = 4.2x10-8). In the secondary analysis (adjusting for RF) the association was less significant (P = 1.7x10-6). In both trans-ethnic primary and secondary meta-analyses 14 regions contained SNPs with associations reaching P<5x10-6; in the European primary and secondary analyses 13 and 10 regions contained SNPs reaching P<5x10-6, respectively. Of the previously validated SNPs for radiological progression, only rs660895 (tagging HLA-DRB1*04:01) attained significance (P = 1.6x10-5) and had a consistent direction of effect across GWAS.

conclusionsOur meta-analysis confirms the known association between the HLA-DRB1 shared epitope and RA radiological damage. The lack of replication of previously validated non-HLA markers highlights a requirement for further research to deliver clinically-useful prognostic genetic markers.

Indexed as

Genome-Wide Association StudyAgedAged, 80 and overArthritis, RheumatoidCohort StudiesEthnicityFemaleHumansMaleMiddle AgedPolymorphism, Single Nucleotide

Identifiers

PMID31596875
PMCPMC6785117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.